Cambridge Investment Research Advisors’s Janus Henderson B-BBB CLO ETF JBBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.77M Buy
37,382
+4,537
+14% +$215K ﹤0.01% 1783
2026
Q1
$1.53M Buy
32,845
+473
+1% +$22.5K ﹤0.01% 1820
2025
Q4
$1.54M Sell
32,372
-28,044
-46% -$1.34M ﹤0.01% 1758
2025
Q3
$2.91M Buy
60,416
+1,427
+2% +$68.9K 0.01% 1235
2025
Q2
$2.84M Sell
58,989
-13,094
-18% -$629K 0.01% 1182
2025
Q1
$3.51M Buy
72,083
+14,714
+26% +$723K 0.01% 994
2024
Q4
$2.82M Buy
57,369
+14,519
+34% +$714K 0.01% 1129
2024
Q3
$2.1M Buy
42,850
+18,688
+77% +$913K 0.01% 1313
2024
Q2
$1.19M Buy
+24,162
New +$1.18M ﹤0.01% 1647

Other funds holding JBBB

Cambridge Investment Research Advisors's JBBB Position: Q2 2026 in Review

Cambridge Investment Research Advisors increased its Janus Henderson B-BBB CLO ETF (JBBB) stake by 14% in Q2 2026, buying an estimated $215K and bringing the position to 37,382 shares worth $1.77M. The position accounts for ﹤0.01% of the portfolio, ranked #1783.

Cambridge Investment Research Advisors first reported a position in JBBB in Q2 2024 and has held it in 9 quarters since. The position peaked at $3.51M in Q1 2025. 94 funds tracked by Wall St. Rank hold JBBB as of Q2 2026.

  • Cambridge Investment Research Advisors held 37,382 shares of Janus Henderson B-BBB CLO ETF worth $1.77M as of Q2 2026.
  • Cambridge Investment Research Advisors bought 4,537 Janus Henderson B-BBB CLO ETF shares in Q2 2026, an estimated $215K.
  • Janus Henderson B-BBB CLO ETF made up ﹤0.01% of Cambridge Investment Research Advisors's portfolio in Q2 2026, its #1783 holding.
  • Cambridge Investment Research Advisors first reported a position in Janus Henderson B-BBB CLO ETF in Q2 2024 and has held it in 9 quarters since.
  • Cambridge Investment Research Advisors's Janus Henderson B-BBB CLO ETF position peaked at $3.51M in Q1 2025.
  • 94 funds tracked by Wall St. Rank held Janus Henderson B-BBB CLO ETF as of Q2 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.